DeuterOncology NV
Entity

  • DeuterOncology NV

    Created in 2020


  • Up & running (A)
    Existing signals show a regular activity

  • Social networks

    338

  • Activities

    deeptech biotech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Clos Chanmurly 13, 4000 Liège, Belgium

    Liège

    Belgium

  • Employees

    Scale: 2-10

    Estimated: 3

  • Engaged catalyst

    0
    0 0

  • Added in Motherbase

    2 years, 2 months ago
Description
  • Value proposition

    Developing deuterated BEST in CLASS MET kinase Inhibitor

    DeuterOncology NV is a Liege based clinical stage biotechnology company that was founded in September 2020 by Dr Timothy Perera. The company is currently focused on the clinical development of a highly selective brain penetrant, deuterated MET kinase inhibitor DO-2.

    Drug Development, Deuterated small molecules, and MET kinase inhibitor

Catalyst interactions
Catalyst TypeTweets Articles
No interactions
Social network dynamics
Similar entities
BETA
Last news
Show all articles